Lonza upgrades growth targets. Lonza Group stock gains 8.79 percent

Published on 10/22/2026 at 10:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Lonza targets 10.00-13.00 percent organic growth over time. Lonza Group stock costs EUR 678.40 on October 22, 2026, 8.79 percent above Xetra close.

Growth model and reporting dates

Lonza set a 10.00-13.00 percent organic growth ambition on October 14, 2026.
Half-year 2026 sales reached CHF 3.40 billion on July 22, 2026.
Lonza Group stock trades at EUR 678.40 at 9:49 a.m. CEST at Lang & Schwarz on October 22, 2026, 8.79 percent above the Xetra close of October 21, 2026.

Isometrische 3D-Illustration einer Pharma-Produktionsanlage mit Tanks, Leitungen und Verpackungslinie — Lonza CH0013841017 isometrische 3D Pharma Anlage mit Tanks Leitungen und Verpackungs Linie, Illustration mit AI erstellt.

Lonza Group (ISIN CH0013841017) is trading at EUR 678.40 at Lang & Schwarz on October 22, 2026 at 9:49 a.m. CEST, up 8.79 percent versus the Xetra close of October 21, 2026 at EUR 623.60. Lonza said on October 14, 2026 that it had upgraded its medium-term growth model while confirming its 2026 outlook.

Three milestones shape the story

The chronology shows a company moving toward a focused contract development and manufacturing organization. On March 2026, Lonza agreed to sell 60 percent of its Capsules and Health Ingredients business in a deal valued at USD 3.00 billion, with completion expected before the end of 2026. On July 22, 2026, its half-year results were released. On October 14, 2026, Lonza set a 10.00-13.00 percent organic constant-currency growth ambition and a core EBITDA margin in the high thirties over the medium term, according to Lonza and Reuters.

What does the margin target mean?

The near-term benchmark is more specific: Lonza reiterated 2026 constant-currency sales growth of 11.00-12.00 percent and a core EBITDA margin of 33.00-34.00 percent. The company said its third-quarter performance was in line with expectations across all business platforms. The half-year 2026 report showed sales of CHF 3.40 billion and core EBITDA of CHF 1.20 billion, figures carried by FinanzNachrichten. For investors, the key issue is execution: the medium-term growth ambition is higher than the 2026 sales outlook, while the margin target moves from a 33.00-34.00 percent near-term range toward the high thirties.

Next dates are already set

Lonza lists November 5, 2026 for the ZKB Swiss Equity Conference and January 27, 2027 for its full-year 2026 results. Both dates appear in the company investor calendar.

Stock rises above the Xetra close

On SIX, Lonza was at CHF 626.80 at 9:43 a.m. CEST on October 22, 2026. The Swiss listing's 52-week range was CHF 454.60 to CHF 628.20, while market capitalization stood at CHF 43.8 billion on the same date. At Lang & Schwarz, Lonza Group stock was trading intraday at EUR 678.40 on October 22, 2026 at 9:49 a.m. CEST, 8.79 percent above the Xetra close of October 21, 2026 at EUR 623.60. The further course of trading is shown by the continuously updated real-time quote of Lonza Group stock.